2022 annual financial data
Redhill Biopharma 2022 Operating margin
Redhill Biopharma 2022 operating margin with verified reported values.
Direct answer
Operating margin was -69.33%.
Operating income was -42,844,000 USD and net income was -71,669,000 USD.
Operating cash flow was -29,185,000 USD.
Get free Redhill Biopharma email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 61,800,000 USD
- Operating income
- -42,844,000 USD
- Net income
- -71,669,000 USD
- Operating cash flow
- -29,185,000 USD